Cas:116409-38-2 [(2R,6S)-2,6-dimethyloxan-2-yl]methanol manufacturer & supplier

Chemical Name:[(2R,6S)-2,6-dimethyloxan-2-yl]methanol

CAS.NO:116409-38-2

Synonyms:trans-2,6-dimethyl-2-hydroxymethyltetrahydropyran;trans-Tetrahydro-2,6-dimethyl-2H-pyran-2-methanol

Molecular Formula:C₈H₁₆O₂

Molecular Weight:144.21100

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:193.727ºC at 760 mmHg

Density:0.934g/cm3

Index of Refraction:1.434

PSA:29.46000

Exact Mass:144.11500

LogP:1.32640

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like trans-2,6-dimethyl-2-hydroxymethyltetrahydropyran chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-Tetrahydro-2,6-dimethyl-2H-pyran-2-methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trans-Tetrahydro-2,6-dimethyl-2H-pyran-2-methanol Use and application,trans-2,6-dimethyl-2-hydroxymethyltetrahydropyran technical grade,usp/ep/jp grade.

Related News: As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made due to the continued drop in demand for travel to China and the US Department of State��s decision to raise its China travel advisory to a Level 4. [(2R,6S)-2,6-dimethyloxan-2-yl]methanol manufacturer Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. [(2R,6S)-2,6-dimethyloxan-2-yl]methanol supplier The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819. [(2R,6S)-2,6-dimethyloxan-2-yl]methanol vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. [(2R,6S)-2,6-dimethyloxan-2-yl]methanol factory There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association.